| Wednesday, September 21, 2005 |
| 6:00pm-7:30pm |
Opening Reception |
| 7:30pm-9:00pm |
VC Dinner (by invitation only) |
| Thursday, September 22, 2005 |
| 7:00am-8:30am |
Continental Breakfast |
| 7:30am-7:45am |
Welcoming Remarks: |
|
The Honorable James C. Greenwood, President and CEO, BIO |
|
Governor Tim Pawlenty |
| 8:00am-9:15am |
Opening Plenary Session: The Future of Emerging Markets in Biotechnology, Pharma, and Medical Devices |
| |
Panel: Mark Kramer, Director, Office of Combination Products, FDA; James E. Thomas, Managing Partner, Thomas McNerney & Partners; Ross Jaffe, Partner, Versant Ventures; David Stack, CEO, Stack Pharmaceuticals, Inc. |
| |
Moderator: Peter J. Ekberg, Partner, Faegre & Benson LLP |
| 9:30am-12:30pm |
Presentations |
| 9:45am-11:00am |
Partnering Workshop: The Future of Strategic Alliances |
| |
Panel: Mark Ungs, Vice President of New Market Development & Emerging Technologies, Cardiovascular Division, Boston Scientific; Dennis Purcell, Managing Director, Perseus-Soros BioPharmaceutical Fund; Denise McGinn, Vice President of Licensing & New Business Development, Pharmaceuticals Group, Johnson & Johnson; Bruce Barclay, President & Chief Operating Officer, SurModics |
| |
Moderator: Stan Duran, Partner, Lifesciences Group, Lindquist & Vennum PLLP |
| 11:15am-12:30pm |
Finance Workshop: Financing Health Care Companies: Trends in Deal Structures, Medical Devise versus Biopharmaceutical Companies, and Financing Companies in Various Geographic Markets. |
| |
Panel: Pete McNerney, Managing Partner, Thomas, McNerney & Partners; John Rice, Managing Partner, Triathlon Medical Ventures; Aron Knickerbocker, Senior Director, Business Development, Genentech, Inc.; Dale Spencer, Founder, ev3 Inc.; Bob Hopkins, Senior Vice President, Lehman Brothers Global Healthcare Research |
| |
Moderator: Bill Kaufman, Oppenheimer Wolff & Donnelly LLP |
| 12:30pm-2:00pm |
Lunch |
| |
Keynote: Building a Successful Midwestern Biopharmaceutical Company |
| |
Speaker: Lonnie Moulder, President and Chief Executive Officer, MGI PHARMA, Inc. |
| 2:15pm-5:00pm |
Presentations |
| 2:30pm-3:45pm |
University Tech Transfer Workshop: Creating Bridges Between the Worlds of University Technologies, Industry, and the Investment Community |
| |
Panel: Dick Sommerstad, Assistant Director, Office of Business Development, University of Minnesota; Gale Kirkpatrick, Director, Scientific Assessment and Technology Licensing, Global Pharmaceutical Licensing & Business Development, Abbott; Marc Malandro, Director, University of Pittsburgh, Office of Technology Management; Paul Bieganski, Managing Director & Chief Technology Officer, Cargill Ventures |
| |
Moderator: Robin Silva, Partner, Chair, Life Sciences & Healthcare Group, Dorsey & Whitney LLP |
| 4:00pm-5:15pm |
Valuation and IP Workshop: Under the Microscope: How IP Valuation Influences Investment Decisions |
| |
Panel: Tim Matheson, Vice President, Baird Venture Partners; Susanne Dvorak, President & CEO, Algos Therapeutics, Inc.; Mark Kassel, Partner, Foley & Lardner LLP; Michael Berman, Investor/Entrepreneur |
| |
Moderator: Paul Wrycha, Partner, Foley & Lardner LLP |
| 6:00pm-9:30pm |
Gala Reception |
| Friday, September 23, 2005 |
| 8:00am-9:30am |
Continental Breakfast |
| 8:30am-9:45am |
Plenary Session: Are We There Yet - Raising a Life Science Company in the Midwest |
| |
Panel: Mark Coticchia, Vice President for Research & Technology Management, Case Western Reserve University; John Huston, Principal, US Private Companies LLC, Ohio Tech Angels Fund; Tim Mayleben, CEO, Avidimer Therapeutics; Art Pappas, Managing Partner, A. M. Pappas & Associates |
| |
Moderator: Jeffrey Fink, Managing Director, Healthcare Investment Banking, Robert W. Baird Co., Inc. |
| 10:00am-12:00pm |
Presentations |
| 10:30am-11:30am |
Convergence Workshop: Biotech - Medical Device Convergence |
| |
Panel: Bill van Antwerp, Vice President & Chief Scientific Officer, Medtronic MiniMed Inc.; John Santini, Ph.D., President & Chief Scientific Officer, MicroCHIPS; Peyton Anderson, CEO, Affinergy, Inc.; Annemarie Moseley, Ph.D., M.D., Chairman, Repair Technologies, Inc. |
| |
Moderators: Tim Conrad, Attorney, Merchant & Gould; Lothar Krinke, Senior Director, Business Development, Medtronic Neurological |
| 12:00pm-1:30pm |
Lunch |
| |
Keynote: Building a 21st Pharmaceutical Company |
| |
Speaker: Josh Boger, President & CEO, Vertex Pharmaceuticals, Inc. |
| 1:45pm-3:00pm |
Presentations |
| 1:45pm-3:00pm |
Reimbursement Workshop: Changes and Trends in Third Party Payer Policy: Impact on Novel Drugs and Devices |
| |
Panel: Elizabeth Brooks, Partner, BioMedical Insights, Inc.; Jayson Slotnik, Director, Medicare Reimbursement & Economic Policy |
| 3:00pm |
Closing Reception |
